A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/728 (2006.01) A61K 38/00 (2006.01) A61K 39/395 (2006.01) A61K 31/725 (1995.01) A61K 7/06 (1995.01)
Patent
CA 2145605
A method for the modulation of cellular activity of tissue and cells expressing an adhesion molecule (for example, ICAM-1, HARLEC, CD44, and RHAMM) of a human is provided the method comprising the administration of a non-toxic effective amount of a form of hyaluronic acid (for example, hyaluronic acid, a salt thereof, [for example, sodium hyaluronate having a molecular weight less than 750,000 daltons, [for example, 225,000 daltons], for example from Hyal Pharmaceutical Corporation within the range of 150,000-225,000 daltons and those disclosed in U.S. Patent Application 08/143983, molecular weight fractions of a form of sodium hyaluronate (for example, fractions disclosed in Canadian Letters Patent 1205031 (to Fidia) such as those from 50,000-100,000 daltons, 250,000-350,000 daltons and 500,000-730,000 daltons, or other fractions, homologues, analogues, derivatives, complexes, esters, fragments and/or sub units of hyaluronic acid and/or combinations thereof) to a human to modulate cellular activity of tissues and/or cells expressing an adhesion molecule in the human body, in a pharmaceutical excipient tolerable by the human (for example, sterile water).
Heenan Blaikie Llp
Hyal Pharmaceutical Corporation
LandOfFree
Modulation of cellular activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of cellular activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of cellular activity will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1594235